摘要
目的检测肺癌组织中促凋亡因子Omi/HtrA2的表达,观察Omi/HtrA2的短发夹状小干扰RNA(shRNA-Omi/HtrA2)载体对肺癌细胞生长的影响。方法采用免疫组织化学SP法检测50例非小细胞肺癌和10例正常肺组织中Omi/HtrA2的表达;将shRNA-Omi/HtrA2载体转染至人肺腺癌细胞株A549,用逆转录-聚合酶链反应(RT-PCR)和Western blot检测其对Omi/HtrA2转录和表达的下调作用,流式细胞术检测Omi/HtrA2下调后A549细胞凋亡的变化。结果Omi/HtrA2在非小细胞肺癌中的表达明显高于正常肺组织(P<0.05)。shRNA-Omi/HtrA2载体能显著抑制A549细胞Omi/HtrA2基因的表达(88%)。转基因组细胞经顺铂处理后凋亡率为(13.00±0.98)%,显著低于对照组的凋亡率(24.00±1.08)%(P<0.05)。结论Omi/HtrA2的高表达参与肺癌的发展,Omi/HtrA2短发夹siRNA可抑制A549细胞的凋亡。
Objective To investigate the expression of pro-apoptotic factor Omi/HtrA2 in lung cancer and to explore the effect of RNA interference targeting Omi/HtrA2 gent on A549 apoptosis. Methods The immunohistochemical system is used to detect the expression of Omi/HtrA2 in tissues from 50 cases lung cancer and 10 normal cases. The effects of shRNA-Omi/HtrA2 on its transcription and translation were analyzed by reverse transeriptase-polyrnerase chain reaction (RT-PCR) and Western blot. The sensitivity of A549 cells to cisplatin (DDP) after Omi/HtrA2 gene silencing was detected by flow cytometry. Results The expression of Omi/HtrA2 in lung cancer was higher than in normal tissues (P 〈 0.05). Omi/HtrA2 expression was inhibited about 88 % ( P 〈 0.05) after shRNA-Omi/HtrA2 transfected. The apoptosis rate of A549 cells to DDP was ( 13.00 ± 0.98) %, while the control group was (24.00 ± 1.08) % (P〈0.05) .Condusion The high expression of Omi/HtrA2 is closely related to the development of lung cancer. The shRNA-Omi/HtrA2 could inhibit the apoptosis of A549 cells.
出处
《中华实验外科杂志》
CAS
CSCD
北大核心
2006年第12期1481-1483,共3页
Chinese Journal of Experimental Surgery
基金
湖北省自然科学基金资助项目(2006ABA109)